PIZZINI, PATRIZIA
PIZZINI, PATRIZIA
Istituto di Fisiologia Clinica - IFC
Active vitamin D treatment in CKD patients raises serum sclerostin and this effect is modified by circulating pentosidine levels
2017 Torino, C.; Pizzini, P.; Cutrupi, S.; Tripepi, G.; Mallamaci, F.; Thadhani, R.; Zoccali, C.
Association between resistin levels and all-cause and cardiovascular mortality: A new study and a systematic review and meta-analysis
2015 Fontana, A; Spadaro, S; Copetti, M; Spoto, B; Salvemini, L; Pizzini, P; Frittitta, L; Mallamaci, F; Pellegrini, F; Trischitta, V; Menzaghi, C
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD
2015 Spoto, B; Mattaceraso, F; Sijbrands, E; Leonardis, D; Testa, A; Pisano, A; Pizzini, P; Cutrupi, S; Parlongo, Rm; D'Arrigo, G; Tripepi, G; Mallamaci, F; Zoccali, C
Asymmetric and Symmetric Dimethylarginine and Sympathetic Nerve Traffic after Renal Denervation in Patients with Resistant Hypertension
2015 Grassi, Guido; Seravalle, Gino; Trevano Fosca, Quarti; Spaziani, Domenico; Scalise, Filippo; Auguadro, Carla; Pizzini, Patrizia; Tripepi, GIOVANNI LUIGI; D'Arrigo, Graziella; Mallamaci, Francesca; Mancia, Giuseppe; Zoccali, Carmine
Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections
2007 Zoccali C; Maas R; Cutrupi S; Pizzini P; Finocchiaro P; Cambareri F; Panuccio V; Martorano C; Schulze F; Enia G; Tripepi G; Boger R
Asymmetric Dimethylarginine (ADMA) Enzymatic Machinery and Adipokines Gene Expression in the Adipose Tissue in Stage 3-5 CKD patients.
2007 Spoto B.; Leonardis D.; Mallamaci F.; Parlongo R.; Pizzini P.; Tripepi G.; Zoccali C.
Asymmetrical Di-Methyl-Arginine (ADMA) predicts progression to dialysis and death in patients with chronic kidney disease (CKD).
2005 Ravani, P; Malberti, F; Testa, S; Cutrupi, S; Pizzini, P; Tripepi, G; Mallamaci, F; Zoccali, C
C-Reactive Protein and Interleukin-6 modify the risk of high levels of Asymmetric Dimethyl-Arginine (ADMA) for death and cardiovascular events in end stage renal diseases patients.
2010 Tripepi G.; Boeger R.; R.Maas R.; Pizzini P.; Cutrupi S.; Zoccali C.
Circulating adiponectin modifies the FGF23 response to vitamin D receptor activation: a post hoc analysis of a double-blind, randomized clinical trial
2018 Spoto, BELINDA GILDA; Pizzini, Patrizia; Tripepi, GIOVANNI LUIGI; Mallamaci, Francesca; Zoccali, Carmine
Circulating soluble RAGE in patients with chronic kidney disease as an inverse correlate of atherosclerosis.
2009 Leonardis, D; Basta, G; Mallamaci, F; Cutrupi, S; Pizzini, P; De Caterina, R; Tripepi, R; Tripepi, G; Zoccali, C
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD).
2011 Leonardis, D; Basta, G; Mallamaci, F; Cutrupi, S; Pizzini, P; Tripepi, R; Tripepi, G; De Caterina, R; Zoccali, C
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease.
2010 Basta, G; Leonardis, D; Mallamaci, F; Cutrupi, S; Pizzini, P; Gaetano, L; Tripepi, R; Tripepi, G; De Caterina, R; Zoccali, C
CKD-MBD biomarkers and CKD progression: an analysis by the joint model
2023 D'Arrigo, Graziella; Mallamaci, Francesca; Pizzini, Patrizia; Leonardis, Daniela; Tripepi, GIOVANNI LUIGI; Zoccali, Carmine
Diagnostic value for low bone turnover of first and second generation immuno-radiometric PTH assay.
2003 Enia, G; Cutrupi, S; Pizzini, P; Tripepi, G; Mallamaci, F; Panuccio, V; Zoccali, C
Does sub-clinical hypothyroidism predict survival in patients on Continuous Ambulatory Peritoneal Dialysis?
2006 Enia G; Cutrupi S; Pizzini P; Tripepi G; Zoccali C.
Effect modification by C-Reactive Protein and Interleukin-6 on the relationship between Asymmetric Dimethyl-Arginine (ADMA), death and cardiovascular events in end stage renal diseases (ESRD) patients.
2010 Tripepi, G; Pizzini, P; Cutrupi, S; Zoccali, C; Mallamaci, F
Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients
2016 Dounousi E.; Torino C.; Pizzini P.; Cutrupi S.; Panuccio V.; D'Arrigo G.; Abd ElHafeez S.; Tripepi G.; Mallamaci F.; Zoccali C.
Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic kidney disease.
2008 Panichi, V; Mantuano, E; Paoletti, S; Santi, S; Manca Rizza, G; Cutrupi, S; Pizzini, P; Spoto, B; Tripepi, G; Zoccali, C
Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients
2017 Torino, Claudia; Pizzini, Patrizia; Cutrupi, Sebastiano; Tripepi, Rocco; Vilasi, ANTONIO DEMETRIO; Tripepi, GIOVANNI LUIGI; Mallamaci, Francesca; Zoccali, Carmine
FGF23 beyond bone mineral metabolism: functional relationship with inflammation in chronic kidney disease patients.
2009 Zoccali, C; Leonardis, D; Catalano, F; Caridi, G; Finocchiaro, P; Panuccio, V; Cutrupi, S; Pizzini, P; Tripepi, G; Mallamaci, F
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Active vitamin D treatment in CKD patients raises serum sclerostin and this effect is modified by circulating pentosidine levels | 1-gen-2017 | Torino, C.; Pizzini, P.; Cutrupi, S.; Tripepi, G.; Mallamaci, F.; Thadhani, R.; Zoccali, C. | |
| Association between resistin levels and all-cause and cardiovascular mortality: A new study and a systematic review and meta-analysis | 1-gen-2015 | Fontana, A; Spadaro, S; Copetti, M; Spoto, B; Salvemini, L; Pizzini, P; Frittitta, L; Mallamaci, F; Pellegrini, F; Trischitta, V; Menzaghi, C | |
| Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD | 1-gen-2015 | Spoto, B; Mattaceraso, F; Sijbrands, E; Leonardis, D; Testa, A; Pisano, A; Pizzini, P; Cutrupi, S; Parlongo, Rm; D'Arrigo, G; Tripepi, G; Mallamaci, F; Zoccali, C | |
| Asymmetric and Symmetric Dimethylarginine and Sympathetic Nerve Traffic after Renal Denervation in Patients with Resistant Hypertension | 1-gen-2015 | Grassi, Guido; Seravalle, Gino; Trevano Fosca, Quarti; Spaziani, Domenico; Scalise, Filippo; Auguadro, Carla; Pizzini, Patrizia; Tripepi, GIOVANNI LUIGI; D'Arrigo, Graziella; Mallamaci, Francesca; Mancia, Giuseppe; Zoccali, Carmine | |
| Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections | 1-gen-2007 | Zoccali C; Maas R; Cutrupi S; Pizzini P; Finocchiaro P; Cambareri F; Panuccio V; Martorano C; Schulze F; Enia G; Tripepi G; Boger R | |
| Asymmetric Dimethylarginine (ADMA) Enzymatic Machinery and Adipokines Gene Expression in the Adipose Tissue in Stage 3-5 CKD patients. | 1-gen-2007 | Spoto B.; Leonardis D.; Mallamaci F.; Parlongo R.; Pizzini P.; Tripepi G.; Zoccali C. | |
| Asymmetrical Di-Methyl-Arginine (ADMA) predicts progression to dialysis and death in patients with chronic kidney disease (CKD). | 1-gen-2005 | Ravani, P; Malberti, F; Testa, S; Cutrupi, S; Pizzini, P; Tripepi, G; Mallamaci, F; Zoccali, C | |
| C-Reactive Protein and Interleukin-6 modify the risk of high levels of Asymmetric Dimethyl-Arginine (ADMA) for death and cardiovascular events in end stage renal diseases patients. | 1-gen-2010 | Tripepi G.; Boeger R.; R.Maas R.; Pizzini P.; Cutrupi S.; Zoccali C. | |
| Circulating adiponectin modifies the FGF23 response to vitamin D receptor activation: a post hoc analysis of a double-blind, randomized clinical trial | 1-gen-2018 | Spoto, BELINDA GILDA; Pizzini, Patrizia; Tripepi, GIOVANNI LUIGI; Mallamaci, Francesca; Zoccali, Carmine | |
| Circulating soluble RAGE in patients with chronic kidney disease as an inverse correlate of atherosclerosis. | 1-gen-2009 | Leonardis, D; Basta, G; Mallamaci, F; Cutrupi, S; Pizzini, P; De Caterina, R; Tripepi, R; Tripepi, G; Zoccali, C | |
| Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD). | 1-gen-2011 | Leonardis, D; Basta, G; Mallamaci, F; Cutrupi, S; Pizzini, P; Tripepi, R; Tripepi, G; De Caterina, R; Zoccali, C | |
| Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease. | 1-gen-2010 | Basta, G; Leonardis, D; Mallamaci, F; Cutrupi, S; Pizzini, P; Gaetano, L; Tripepi, R; Tripepi, G; De Caterina, R; Zoccali, C | |
| CKD-MBD biomarkers and CKD progression: an analysis by the joint model | 1-gen-2023 | D'Arrigo, Graziella; Mallamaci, Francesca; Pizzini, Patrizia; Leonardis, Daniela; Tripepi, GIOVANNI LUIGI; Zoccali, Carmine | |
| Diagnostic value for low bone turnover of first and second generation immuno-radiometric PTH assay. | 1-gen-2003 | Enia, G; Cutrupi, S; Pizzini, P; Tripepi, G; Mallamaci, F; Panuccio, V; Zoccali, C | |
| Does sub-clinical hypothyroidism predict survival in patients on Continuous Ambulatory Peritoneal Dialysis? | 1-gen-2006 | Enia G; Cutrupi S; Pizzini P; Tripepi G; Zoccali C. | |
| Effect modification by C-Reactive Protein and Interleukin-6 on the relationship between Asymmetric Dimethyl-Arginine (ADMA), death and cardiovascular events in end stage renal diseases (ESRD) patients. | 1-gen-2010 | Tripepi, G; Pizzini, P; Cutrupi, S; Zoccali, C; Mallamaci, F | |
| Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients | 1-gen-2016 | Dounousi E.; Torino C.; Pizzini P.; Cutrupi S.; Panuccio V.; D'Arrigo G.; Abd ElHafeez S.; Tripepi G.; Mallamaci F.; Zoccali C. | |
| Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic kidney disease. | 1-gen-2008 | Panichi, V; Mantuano, E; Paoletti, S; Santi, S; Manca Rizza, G; Cutrupi, S; Pizzini, P; Spoto, B; Tripepi, G; Zoccali, C | |
| Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients | 1-gen-2017 | Torino, Claudia; Pizzini, Patrizia; Cutrupi, Sebastiano; Tripepi, Rocco; Vilasi, ANTONIO DEMETRIO; Tripepi, GIOVANNI LUIGI; Mallamaci, Francesca; Zoccali, Carmine | |
| FGF23 beyond bone mineral metabolism: functional relationship with inflammation in chronic kidney disease patients. | 1-gen-2009 | Zoccali, C; Leonardis, D; Catalano, F; Caridi, G; Finocchiaro, P; Panuccio, V; Cutrupi, S; Pizzini, P; Tripepi, G; Mallamaci, F |